company? Let’s change
that.
Don't see your company?
Create a company profileGossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
Accord Biomaterials, Inc. develops chemistries and coatings for medical device protection. It offers Nogen that are catalytic nitric oxide
ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD).
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
OncoFusion Therapeutics is engaged in the R&D of personalized therapeutics for patients with genetically defined cancers.
Accuri Cytometers is a medical device company developing cost effective cytometers for laboratories.
Official LinkedIn page for Esperion. Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines accessible. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc. Community guidelines: https://bit.ly/3vLCGdO
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP, P450, AChE and BChE Activity among others.
The Life Sciences business of Truven Health Analytics (www.truvenhealth.com/life-sciences) is a trusted, full service market access, stakeholder management, and health economics and outcomes research (HEOR) consultancy serving the global pharmaceutical, medical device and biotech industry. With the 2014 acquisition of Heartbeat Experts (www.heartbeatexperts.com) into our Life Sciences business, we offer the leading KOL and market access stakeholder identification, profiling, mapping and engagement solutions. Truven Health Life Sciences enables our 150+ customers to effectively reach out to the right people with the right scientific evidence to demonstrate product value – anywhere in the world. (www.truvenhealth.com/life-science)
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
MMS is an award-winning, global clinical research organization (CRO) that supports leading pharmaceutical and biotech companies as well as many smaller enterprises across our spectrum of services. Having completed more than 50 submissions for drug approval over the last 5 years, we remain a top choice for sponsors who are looking for innovation and demand high quality from their CRO partners. Senior leadership at MMS has more than two decades of hands-on drug development experience which helps support program-level strategy and execution of projects across multiple therapeutic areas. Continual staff training, innovative recruitment and motivating career opportunities help MMS retain the best talent and develop a strong, client-focused workforce across all global locations. Our mission is to deliver high-quality services, rooted in good science and decades of regulatory experience, that will assist our clients in developing and marketing life-changing therapies, thereby positively affecting patients' lives worldwide.
Work Your Passion. Live Your Purpose.